MLchartDataset catalogue

anti-CEA/anti-4-1BB bispecific antibody LM-24C5

Term · Oncology and biomedicine · MLC-T-ONC-010463

A bispecific antibody targeting both the tumor-associated antigen (TAA) carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5; CEA) and the costimulatory receptor 4-1BB (CD137; tumor necrosis factor receptor superfamily member 9; TNFRSF9), with potential immunostimulating and antineoplastic activities. Upon administration, anti-CEA/anti-4-1BB bispecific antibody LM-24C5 simultaneously targets and binds to CEA expressed on tumor cells and 4-1BB expressed on activated T lymphocytes and natural killer (NK) cells. This crosslinks CEA-expressing tumor cells and 4-1BB-expressing T cells and NK cells, and activates 4-1BB signaling locally in the tumor microenvironment (TME). This results in cytotoxic T-cell co-stimulation, enhances T-lymphocyte-mediated anti-tumor activity and leads to cytotoxic T-cell-mediated lysis of CEA-expressing tumor cells. CEA is overexpressed by a variety of cancer cell types and plays a key role in cell migration, cell invasion, and cell adhesion. 4-1BB, a surface glycoprotein of the tumor necrosis factor receptor superfamily, is an inducible costimulatory receptor that plays a key role in T-cell proliferation, survival and cytolytic activity.

Table 1. Record
IdentifierMLC-T-ONC-010463
FieldOncology and biomedicine
Synonymsanti-4-1BB/CEA bispecific antibody LM-24C5; anti-CEA/4-1BB bispecific antibody LM-24C5; anti-CEACAM5/anti-4-1BB bispecific antibody LM-24C5; anti-CEACAM5/anti-CD137 bispecific antibody LM-24C5; CEA x 4-1BB bispecific antibody LM-24C5
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010463",
  "term": "anti-CEA/anti-4-1BB bispecific antibody LM-24C5",
  "field": "Oncology and biomedicine",
  "definition": "A bispecific antibody targeting both the tumor-associated antigen (TAA) carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5; CEA) and the costimulatory receptor 4-1BB (CD137; tumor necrosis factor receptor superfamily member 9; TNFRSF9), with potential immunostimulating and antineoplastic activities. Upon administration, anti-CEA/anti-4-1BB bispecific antibody LM-24C5 simultaneously targets and binds to CEA expressed on tumor cells and 4-1BB expressed on activated T lymphocytes and natural killer (NK) cells. This crosslinks CEA-expressing tumor cells and 4-1BB-expressing T cells and NK cells, and activates 4-1BB signaling locally in the tumor microenvironment (TME). This results in cytotoxic T-cell co-stimulation, enhances T-lymphocyte-mediated anti-tumor activity and leads to cytotoxic T-cell-mediated lysis of CEA-expressing tumor cells. CEA is overexpressed by a variety of cancer cell types and plays a key role in cell migration, cell invasion, and cell adhesion. 4-1BB, a surface glycoprotein of the tumor necrosis factor receptor superfamily, is an inducible costimulatory receptor that plays a key role in T-cell proliferation, survival and cytolytic activity.",
  "synonyms": [
    "anti-4-1BB/CEA bispecific antibody LM-24C5",
    "anti-CEA/4-1BB bispecific antibody LM-24C5",
    "anti-CEACAM5/anti-4-1BB bispecific antibody LM-24C5",
    "anti-CEACAM5/anti-CD137 bispecific antibody LM-24C5",
    "CEA x 4-1BB bispecific antibody LM-24C5"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-cea-anti-4-1bb-bispecific-antibody-lm-24c5/"
}

Record 1,553 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.